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We previously demonstrated the presence of regulatory
T cells (Tregs) in lymph nodes (LNs) from rats made tolerant
to a kidney allograft by donor peripheral blood mononuclear
cell (PBMC) infusion. Here, we investigated the origin of
Treg and characterized their phenotype and mechanisms
underlying their suppressive effect. At different points
after PBMC infusion, thymus, LN, and graft-infiltrating
–lymphocyte’s (GIL) alloreactivity was evaluated in mixed
lymphocyte reaction (MLR), coculture, and transwell
experiments. GIL phenotype (by fluorescence-activated cell
sorting and immunohistochemistry) and cytokines mRNA
expression were analyzed. Before transplantation, CD4þ
thymocytes and LN cells from donor PBMC-infused rats
showed a reduced anti-donor but a normal anti-third-party
proliferation. Anti-donor hyporesponsiveness was reverted
by interleukin (IL)-2. CD4þ thymocytes had no regulatory
activity on a naı¨ve MLR. Treg appeared in LN at 60 days
post-transplant. CD4þ -GIL isolated early (5 days) and late
post-transplant (days 60–80) were hyporesponsive and
suppressed a naı¨ve MLR. IL-10 mRNA was upregulated
in GIL and an anti-IL-10 monoclonal antibody reverted
their inhibitory effect. Cell-to-cell contact potentiated the
suppressive activity of CD4þ -GIL. We suppose that allograft
tolerance in this model is mediated by pretransplant
generation of anergic cells in the thymus, which may have
a permissive role to prevent early graft disruption. The
healed graft is a source of donor antigens, which led to
early selection of Treg. In the late phase, tolerance is
maintained by appearance of Treg in LN.
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Donor-leukocyte infusion is an efficient strategy to induce
tolerance in many experimental models1,2 and the beneficial
effects of donor-specific transfusions have also been observed
clinically in recipients of renal and cardiac transplants.3,4
We have documented that a single pretransplant intravenous
infusion of donor peripheral blood mononuclear cells
(PBMCs) into rat recipients promoted donor-specific
tolerance of a subsequent kidney allograft from major histo-
compatibility complex (MHC)-incompatible rats.5 By the
analysis of microchimerism in different organs and tissues,
the tolerogenic potential of PBMC infusion related to
the capability of these cells to engraft the recipient thymus.6
The role of intrathymic microchimerism was reinforced by
findings that thymectomy at the time of transplant prevented
tolerance induction by donor leukocytes.6
It has been proposed previously that clonal deletion into
the thymus of donor-reactive T cells may be responsible for
tolerance induction by donor cell infusion.7–9 Data are also
available that the generation of regulatory cells (Treg) has a
role in the induction and maintenance of the unresponsive
state in several models of tolerance in rodents, by interacting
with the host T cells in the peripheral lymphoid organs.10–12 In
this regard, we have recently demonstrated the appearance of
CD4þCD25þ Treg in lymph node (LN) and in the grafts from
long-term surviving rats tolerized by donor PBMC infusion.13
The general aim of this study was to deepen our insight
into the mechanisms underlying tolerance induction in
our model. Specific aims were: (1) to establish the origin
of Treg and particularly whether they are formed centrally
in the thymus or peripherally in LN or in the graft; (2) to
characterize the phenotype of Treg; and (3) to find out the
molecular mechanism underlying their suppressive effect.
RESULTS
Donor PBMC infusion per se induces T-cell
hyporesponsiveness but not regulation in LNs and in the
thymus
To investigate the mechanisms underlying tolerance induc-
tion in our model, we first evaluated the effect of donor
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Brown Norway (BN)-PBMC infusion per se on T-cell func-
tion in the lymphoid organs of Lewis rat (LW) recipients.
A significantly (Po0.05) lower proliferative response against
donor BN but not against third-party Wistar Furth rat (WF)
splenocytes was found in LN cells isolated 20 days after donor
PBMC infusion (day 0), compared with LN cells from naı¨ve
rats (Figure 1a). The anti-donor hyporesponsiveness was
completely reverted by 50 U/ml IL-2 to such a degree that
the proliferative response against donor stimulators was
comparable to that of naı¨ve LN cells (Table 1), suggesting the
generation of anergic cells. A lower dose of IL-2 (10 U/ml)
only partially restored anti-donor response of LN cells from
BN-PBMC-infused rats (LN from PBMC-infused rats, no
IL-2: 28 544 c.p.m., with 10 U/ml IL-2: 75 548 c.p.m.; LN
from naı¨ve rats, no IL-2: 72 120 c.p.m., with 10 U/ml IL-2:
136 095 c.p.m.). These data indicate that high dose of IL-2 is
required to recover anergic T cells, consistent with previously
reported data.14 On the other hand, the anti-third-party
alloreactivity was comparable in the two groups either in the
presence or in the absence of IL-2 (Table 1). To evaluate
whether hyporesponsive LN cells from LW animals infused
with donor PBMC had regulatory activity, these cells were
cultured with naı¨ve LN cells stimulated by irradiated
allogeneic splenocytes (naı¨ve mixed lymphocyte reaction
(MLR)). No regulatory activity was found on a naı¨ve MLR
toward either donor BN or third-party stimulators
(Figure 1b).
In previous studies, we found that the tolerogenic poten-
tial of donor PBMC related to the capability of these cells to
engraft the recipient thymus as thymectomy performed at the
time of transplantation prevented tolerance induction.6 Thus,
we further evaluated whether hyporesponsive T cells were
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Figure 1 | Proliferative response and immunomodulatory activity of LN cells and thymocytes from BN-PBMC-treated LW rats before
transplantation. (a) 1 106 LN cells from naı¨ve LW rats (n¼ 10) or from BN-PBMC (isolated 20 days after PBMC infusion, day 0) rats (n¼ 9) were
cultured for 5 days with 1 106 irradiated LW (syngeneic), BN (allogeneic, open bars), or WF (third party, hatched bars) splenocytes. (b) 1 106
LN cells were cultured for 5 days with 1.5 106 irradiated LW (syngeneic), BN (allogeneic, open bars), or WF (third party, hatched bars)
splenocytes in the presence of 0.5 106 LN cells isolated from naı¨ve (n¼ 10) or BN-PBMC (day 0) animals (n¼ 9). (c) 1 106 CD4þ thymocytes
from naı¨ve LW rats (n¼ 7) or from BN-PBMC (day 0) rats (n¼ 5) were cultured for 5 days with 1 106 irradiated LW (syngeneic), BN
(allogenic, open bars), or WF (third party, hatched bars) splenocytes. (d) 1 106 LN cells were cultured for 5 days with 1.5 106 irradiated
LW (syngeneic), BN (allogeneic, open bars), or WF (third party, hatched bars) splenocytes in the presence of 0.5 106 CD4þ thymocytes
isolated from naı¨ve (n¼ 5) or from BN-PBMC (day 0) animals (n¼ 5). Results of control naı¨ve LN MLR are on left: BN (allogeneic, open bars)
or WF (third party, hatched bars) (n¼ 4). Proliferation was measured by incorporation of 3H-thymidine and expressed as stimulation index.
JPo0.05 vs naı¨ve by analysis of variance.
Kidney International (2007) 71, 1132–1141 1133
RA Cavinato et al.: Role of thymic- and graft-dependent mechanisms in tolerance induction o r i g i n a l a r t i c l e
generated in the thymus of donor PBMC-treated animals.
The proliferative response of single positive CD4 thymocytes
isolated 20 days after PBMC infusion (day 0) against donor
BN stimulators was significantly (Po0.05) lower than that of
CD4þ thymocytes from naı¨ve LW rats (Figure 1c). The anti-
third-party alloreactivity, however, was normal (Figure 1c).
Anti-donor hyporesponsiveness was almost completely rever-
ted by addition of 50 U/ml IL-2 (Table 1), suggesting that
anergy occurred. Addition of CD4þ thymocytes from
PBMC-infused rats did not modify the proliferative response
of naı¨ve LN cells against donor stimulators, excluding the
formation of Treg in the thymus pretransplant (Figure 1d).
Tregs appear in the LNs of tolerant animals late after
transplant
In a previous study, we documented that Treg can be detected
in LN of long-term-kidney-allograft rat recipients.13
To investigate the timing of Treg formation, we performed
sequential MLRs using as responders LN cells isolated 5, 15,
30, and 60–80 days post-transplant from rats previously
exposed to donor PBMC. All transplanted animals had a
well-functioning graft at the time of killing.
Alloreactivity of LN cells isolated early post-transplant
(day 5 and 15) against donor BN splenocytes did not differ at
significant extent from the response of naı¨ve LN cells (Figure
2a). By contrast, a significant (Po0.05) anti-donor hypo-
responsiveness, compared with naı¨ve responders, was found
starting from day 30 post-transplant and persisted thereafter
(Figure 2a). The anti-third-party alloreactivity was not
significantly reduced compared with naı¨ve LN cells (Figure 2a).
In selected experiments (n¼ 2), a LN biopsy was taken at
15 days post-transplant for MLR and the animals were left
alive. LN from both animals showed a vigorous anti-donor
response (stimulation index: 16.5 and 11) at 15 days albeit
both achieved long-term survival (460 days).
LN cells taken early after transplantation (5 and 15 days)
failed to downregulate the alloreactivity of naı¨ve LN cells
against either donor BN or third-party alloantigens (Figure
2b). By contrast, a donor-specific regulatory effect appeared
in LN cells from day 30 and became significant at day 60–80
post-transplant (Figure 2b). Thus, Treg appear in the LN of
rats preinfused with donor PBMC, late after kidney
transplant. We then investigated the possible thymic origin
of Treg. As shown in Figure 2c, the proliferative response of
naı¨ve LN cells against either donor or third-party spleno-
cytes, in the presence of CD4þ thymocytes taken either 5 or
30 days post-transplant, was not different from that of naı¨ve
LN cells cocultured with naı¨ve CD4þ thymocytes. In addi-
tion, thymectomy performed at day 30 post-transplant in
PBMC-infused animals (n¼ 3) had no effect on graft survival
to the extent that all the thymectomized rats maintained their
well-functioning graft till day 490 post-transplant. Al-
together these results indicate that the thymus has no relevant
role in the maintenance phase of tolerance in this model.
Detection of kidney graft-infiltrating lymphocytes
with regulatory activity in donor PBMC-infused rats
In rats preinfused with BN-PBMC, the percentage of CD4þ
T-cells infiltrating the graft at day 5 post-transplant was
higher (Po0.05) than that in kidneys from untreated animals
rejecting their graft (Table 2) and further increased in the
grafts taken 60–80 days after surgery (Po0.05 vs rejecting
grafts). By contrast, the percentages of both CD8þ T cells
and of antigen-presenting cell (MHCIIþ ) were significantly
lower in the kidney grafts taken both early and late post-
transplant from donor PBMC-pre-exposed rats than in
rejected grafts from untreated animals (Table 2). The propor-
tion of CD4þ T cells expressing the CD25 marker was
comparable in the three groups of rats (Table 2). We then
performed immunofluorescence analysis on kidney tissues
taken from infused rats killed at 5 (n¼ 3) and 60 (n¼ 3) days
post-transplant and from untreated animals rejecting their
graft (n¼ 3) to look for CD4þ T cells that coexpress Foxp3.
We found a dramatic increase in the percentage of CD4þ
T cells expressing Foxp3þ in the grafts from donor PBMC-
rats, taken both early (22.51710.04%, Po0.05 vs untreated
animals) and late post-transplant (11.9570.49%, Po0.05 vs
untreated animals) compared with rejected grafts from
untreated animals (0.9870.31%, Figure 3).
CD4þ T cells purified from graft-infiltrating lymphocyte
(GIL) (CD4þ -GIL) taken early post-transplant (day 5)
from donor PBMC-pre-exposed rats were hyporesponsive
in MLR to donor BN and third-party stimulators compared
with naı¨ve LN CD4þ T cells (Figure 4a). Addition of 50 U/ml
of IL-2 to GIL reversed both anti-donor and anti-third-
party hyporesposiveness (Table 1). Similar results were
detected using CD4þ -GIL isolated 60–80 days post-trans-
plant (Figure 4a).
Compared with naı¨ve LN CD4þ T cells, CD4þ -GIL
isolated from donor PBMC preinfused rats at 5 and 60–80
days post-transplant inhibited the proliferation of naı¨ve
Table 1 | Effect of IL-2 on MLR of cells from naı¨ve and
BN-PBMC infused rats
CPM
Group IL-2 vs donor BN vs third-party WF
BN-PBMC LN cells  34 867 (9064)* 58 341 (11 678)
+ 175 069 (17 256) 163 971 (26 524)
Naı¨ve LN cells  102 540 (18 639) 85 864 (5207)
+ 156 791 (23 863) 153 611 (20 026)
BN-PBMC thymocytes  17 153 (3517)* 28 149 (832)
+ 115 505 (20 876) 163 030 (3875)
Naı¨ve thymocytes  28 687 (4013) 25 400 (5759)
+ 137 566 (28 930) 160 635 (6544)
BN-PBMC CD4+ -GIL  2279 (137) 2385 (138)
+ 27 448 (5597) 31 183 (538)
BN, Brown Norway; CPM, counts per minute; GIL, graft infiltrating lymphocytes; IL,
interleukin; MLR, mixed lymphocyte reaction; WF, Wistar-Furth; PBMC, peripheral
blood mononuclear cell.
MLR was performed in the absence or presence of 50 IU/ml recombinant IL-2. LN
cells and thymocytes were isolated from naı¨ve or BN-PBMC-infused rats before
kidney transplantation. CD4+-GIL cells were isolated from PBMC-infused rats at 5
days post-transplant. Cell purification and MLR were performed as described in
Materials and Methods. The proliferative response is expressed in CPM. Data are the
mean7s.e. (in parantheses). *Po0.05 vs naı¨ve by analysis of variance.
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LN against either donor BN or third-party splenocytes
(Figure 4b).
In additional coculture experiments, CD4þCD25þ T cells,
purified from GIL of animals killed 60–80 days after
transplantation significantly (Po0.05 vs naı¨ve LN cells)
downregulated the immune response of naı¨ve T cells against
donor BN. CD4þCD25 T cells showed inhibitory activity
as well, although to a lesser degree than CD4þCD25þ T cells
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Figure 2 | Proliferative response and immunomodulatory activity of LN cells and thymocytes from BN-PBMC-treated LW rats after
transplantation. (a) 1 106 LN cells from naı¨ve LW rats (n¼ 10) or from BN-PBMC rats killed at different times after kidney transplant (day 5,
n¼ 8; day 15, n¼ 3; day 30, n¼ 3; day 60–80, n¼ 10) were cultured for 5 days with 1 106 irradiated LW (syngeneic), BN (allogeneic, open bars),
or WF (third party, hatched bars) splenocytes. (b) 1 106 LN cells were cultured for 5 days with 1.5 106 irradiated LW (syngeneic), BN
(allogeneic, open bars), or WF (third party, hatched bars) splenocytes in the presence of 0.5 106 LN cells isolated from naı¨ve (n¼ 10) or
BN-PBMC animals killed at different times after kidney transplant (day 5, n¼ 8; day 15, n¼ 3; day 30, n¼ 3; day 60–80, n¼ 10). (c) 1 106 LN
cells were cultured for 5 days with 1.5 106 irradiated LW (syngeneic), BN (allogeneic, open bars), or WF (third party, hatched bars) splenocytes
in the presence of 0.5 106 CD4þ thymocytes isolated from naı¨ve (n¼ 3), BN-PBMC (day 5) (n¼ 3), or BN-PBMC (day 30) animals (n¼ 3).
Proliferation was measured by incorporation of 3H-thymidine and expressed as stimulation index. JPo0.05 vs naı¨ve by analysis of variance.
Table 2 | Phenotypic characteristics of GIL 5 and 60–80 days post-transplant
Group Killed (days post-Tx) % CD4+ % CD25+ on CD4+ % CD8+ % MHCII+
Untreated+BN kidney 5 *4.9 (0.8)# 11.57 (2.0) *23 (2.1)# *37 (1.9)#
BN-PBMC+BN kidney 5 11.7 (1.1) 11.70 (3.7) 12.1 (1.6)# 22.3 (1.6)#
BN-PBMC+BN kidney 60–80 17 (4.0) 8.40 (5.0) 5.7 (1.2) 14 (2.0)
BN, Brown Norway; GIL, graft infiltrating lymphocytes; MHC, major histocompatibility complex; PBMC, peripheral blood mononuclear cell; Tx, transplant.
GILs were obtained as described in Materials and Methods.
The percentage of positive cells was determinated by FACS analysis. Data are the mean7s.e. (in parantheses). #Po0.05 vs 60–80 days, *Po0.05 vs 5 days BN-PBMC by analysis
of variance.
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(Figure 4c). In selected experiments, CD4þCD25þ T subset
from GIL of long-term surviving rats (460 days, n¼ 2)
suppressed an anti-third-party MLR as well, whereas the
CD4þCD25 fraction was less effective (Figure 4d), confir-
ming that the regulatory activity was concentrated within
CD4þCD25þ T cells.
Phenotypic and functional characterization of regulatory
cells in the grafts
CD4þ -GIL isolated either 5 or 60–80 days post-transplant
showed a dramatic upregulation of IL-10 mRNA expression
compared with control CD4þ -naı¨ve T cells (Figure 5a).
Interferon (IFN)g mRNA in CD4þ -GIL was about 10-fold
higher than in control cells. On the other hand, IL-2 expres-
sion level was similar in CD4þ -GIL and in CD4þ -naı¨ve
T cells (Figure 5a). For comparison, we analyzed cytokine
profile in CD4þ -GIL isolated on day 5 post-transplant from
untreated recipients and found similar IL-10 mRNA levels
but a higher expression of IFNg and IL-2 compared with
CD4þ -GIL from PBMC-treated rats.
When CD4þ -GIL isolated 60–80 days post-transplant
were stimulated with donor BN splenocytes in the upper
compartment of a transwell system, they exerted a significant
(Po0.05 vs medium) inhibitory effect on anti-donor proli-
ferative response of naı¨ve LN cells in the lower compartment
(Figure 5b). However, a stronger inhibitory effect was
observed when CD4þ -GIL were incubated with naı¨ve LN
cells in a standard coculture MLR (Po0.05 vs transwell).
Addition of an anti-IL-10 antibody to coculture MLRs
significantly reverted the suppressive effect of CD4þ -GIL,
isolated either 5 days or 60–80 days post-transplant, on the
proliferative response of naı¨ve LN cells against donor spleno-
cytes (Po0.05 vs CD4þ -GIL without IL-10) (Figure 5c).
Altogether these results support that both IL-10 released
in the supernatant and cell-to-cell contact are involved in
the regulatory activity of CD4þ -GIL isolated from PBMC-
tolerized kidney grafts. To evaluate functional in vivo
properties of Treg infiltrating the graft, we performed
adoptive transfer experiments with GIL taken from infused
rats killed at day 5 post-transplant (n¼ 2) and at day 60
post-transplant (n¼ 2). Each GIL suspension (20 106) was
pooled with 80 106 naı¨ve spleen cells and intravenously
infused in lightly irradiated (200 rad) LW naı¨ve rats, 24 h
before transplantation of a BN kidney. Survival times were as
follows: recipients of GIL isolated at day 5 post transplant: 25,
80 days; recipients of GIL isolated at day 60 post transplant,
23, 31 days; controls (recipients of 100 106 naı¨ve spleen
cells): 9, 15 days.
DISCUSSION
We previously reported that Treg accumulate in lymphoid
organs of rats made tolerant to a kidney allograft by
donor-PBMC infusion.13 Here, we found that development
of tolerance in this model implies a three-step process:
a pretransplant phase occurring centrally in the thymus,
an early post-transplant phase in the graft, and a late
maintenance thymus-independent phase in peripheral
lymphoid organs. The thymic-dependent phase occurred
before transplant and led to the generation of anergic CD4þ
T cells in the thymus. These cells displayed donor-specific
hyporesponsiveness, but no regulatory activity. The same
functional characteristics were found in T cells taken from
LN at the same time point. The second step was characterized
by the appearance of regulatory CD4þ T cells in the graft,
but not in lymphoid organs, early post-transplant. Finally,
late post-transplant Treg were also detected in the peripheral
lymphoid organs. CD4þ T cells accumulating in the graft
expressed Foxp3þ , a transcription factor required for Treg
development and function,15 expressed very high levels of the
immunomodulatory cytokine IL-10 and their suppressive
effect was both IL-10- and cell-to-cell contact-dependent.
In models of mixed chimeras created by bone-marrow
transplantation combined with either host irradiation16 or
costimulatory blockade,17 tolerance is predominantly asso-
a b c
Figure 3 | Immunofluorescence staining for CD4þFoxp3þ T cells in rat kidney allografts. Representative microphotographs of staining
for CD4 (phycoerythrin-conjugated anti-rat CD4mAb, digitally converted in green to increase visibility) and Foxp3 (shown in red, anti-rat
Foxp3mAb and Cy5-conjugated goat anti-rabbit as secondary antibody) on kidney tissue from BN-PBMC-infused rats killed (a) 5 days and (b) 60
days post-transplant and from an untreated rat killed 5 days post-transplant (c) Original magnification  400. Interstitial CD4þ T cell
infiltrates are shown. In kidney grafts from BN-PBMC rats (both at 5 and 60 days post-transplant), several CD4þ T cells coexpress Foxp3
(indicated by arrows), whereas in the rejected kidney graft from untreated rats very few Foxp3þ cells are present.
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ciated with intrathymic clonal deletion of donor-reactive cells
that is mediated by the presence of donor-derived anti-
gen-presenting cell in the thymus. Intrathymic micro-
chimerism plays a main role in our model of tolerance.6
However, here we found that anti-donor hyporesponsiveness
of CD4þ thymocytes from donor PBMC-treated rats was
almost completely reverted by high dose of IL-2, indicating
that anergy, rather than deletion, is involved in the thymic
phase of tolerance. We speculate that the fate of anti-donor-
reactive thymocytes depends on the amount of donor
antigens within the thymus: high antigen levels presented
by donor antigen-presenting cell in mixed chimeras would
deliver a strong signal to maturing thymocytes resulting
in deletion, whereas a weaker signal delivered by few donor
cells, as we found in our model,6 would generate anergic
thymocytes. This interpretation is in line with previous data
that a large inoculum of donor bone marrow in mice
produces significant deletion of antigen-reactive cells,
whereas a low marrow dose generates anti-donor unrespon-
sive T cell clones with little evidence of clonal deletion.18
Peripheral LN cells from long-term surviving animals
receiving a kidney transplant after donor-PBMC infusion had
potent regulatory activity on naı¨ve T cells in vitro and
in vivo.13 This finding is consistent with studies showing that
Treg participate to maintain stable skin allograft tolerance
induced by bone-marrow transplantation under rapamycin
and costimulation blockade.19 The role of Treg has been
clearly documented in the maintenance phase of other models
of tolerance induced by donor cell infusion.20–22 However, the
mechanisms underlying Treg formation remained obscure.
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Figure 4 | Proliferative and immunomodulatory activity of CD4þ T cells from GIL of BN-PBMC-treated LW rats. (a) 1 106 responder
CD4þ T cells from GIL of BN-PBMC (day 5) (n¼ 3) or BN-PBMC (days 60–80) (n¼ 3) rats were cultured for 5 days with 1 106 irradiated
LW (syngeneic), BN (allogeneic, open bars), or WF (third party, hatched bars) splenocytes. MLR with CD4þ T cells isolated from naı¨ve LW LN
were used as controls (n¼ 4). (b) 1 106 naı¨ve LN cells were cultured for 5 days with 1.5 106 irradiated LW (syngeneic), BN (allogeneic,
white bars), or WF (third party, hatched bars) splenocytes in the presence of 0.5 106 CD4þ T cells isolated from GIL of BN-PBMC (day 5, n¼ 7)
or BN-PBMC (days 60–80, n¼ 7) animals. Naı¨ve MLR in the presence of 0.5 106 CD4þ T cells from naı¨ve LW LN were used as controls (n¼ 4).
(c) 1 106 naı¨ve LN cells were cultured for 5 days with 1.5 106 irradiated LW (syngeneic) or BN (allogeneic) splenocytes in the presence
of 0.5 106 naı¨ve LN CD4þ T cells (as control, n¼ 5) or with 0.5 106 total CD4þ T cells (n¼ 7), or CD4þCD25þ (n¼ 5) or CD4þCD25
T cell subsets (n¼ 5) isolated from GIL of BN-PBMC (days 60–80) rats. (d) 1 106 naı¨ve LN cells were cultured with 1.5 106 irradiated
third party WF splenocytes in the presence of 0.5 106 CD4þ T cells isolated from naı¨ve LN (as control) or with 0.5 106 CD4þ T cells
isolated from GIL of BN-PBMC (day 60, n¼ 2) rats divided in CD4þCD25þ and CD4þCD25 T cell subset. Proliferation was measured by
incorporation of 3H-thymidine and was expressed as stimulation index. JPo0.05 vs naı¨ve, by analysis of variance.
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It is well known that naturally occurring CD4þ T cells
capable of regulating autoimmunity originates in the
thymus,23 but the thymic dependency of Treg induced after
transplantation is less clear.24–26 Onodera et al.27 showed that
thymus was required for generation of Treg under the cover
of CD4 monoclonal antibody (mAb) therapy in sensitized
rats as documented by the inability of spleen cells from
thymectomized CD4 mAb-treated hosts to confer tolerance
to naı¨ve animals. On the other hand, in our model, CD4þ
thymocytes isolated either before or at 5 and 30 days after
transplantation had no regulatory activity and tolerant rats
that underwent thymectomy at day 30 post-transplant
maintained tolerance to kidney allograft, thus excluding that
Treg were directly formed in the thymus.
We then analyzed the timing of peripheral development of
Treg and found no regulatory activity in LN cells isolated
from recipient rats before transplant and at 5 and 15 days
post-transplant in coculture MLR, and adoptive transfer of
splenocytes isolated at day 5 post-transplant into naı¨ve rats
failed to prolong the survival of a kidney allograft (median
survival: 7 days, n¼ 3). This is consistent with previous
reports in experimental models of tolerance,28–30 showing
that Treg may take weeks to appear in LN. Accordingly, these
reports emphasize the role of Treg in the maintenance of
tolerance rather than in its induction.
On the other hand, we found a higher percentage
of CD4þ T cells that express Foxp3 as early as 5 days post-
transplant in the grafts of donor-PBMC-treated rats than in
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Figure 5 | Functional characterization of regulatory cells from BN-PBMC treated rats. (a) CD4þ T cells were purified from GIL of BN-PBMC-
infused rats killed 5 and 60–80 days after BN kidney transplant. mRNA expression was evaluated by real time reverse transcriptase-polymerase
chain reaction. The cDNA content in each sample was calculated by DDCT technique, using as calibrator the cDNA expression in CD4þ T cells
from naı¨ve LN cells. These data are representative of three independent experiments. (b) 0.5 106 CD4þ -GIL from BN-PBMC (days 60–80)
rats (n¼ 3) stimulated with 0.5 106 irradiated BN splenocytes were added in the upper compartment of a transwell system (gray bar), whereas
a primary MLR (1 106 LW LN cells stimulated with 1 106 irradiated BN splenocytes) was cultured in the bottom compartment. In additional
transwells, medium alone was placed in the upper compartment and was used as control (open bar). Results of standard cocultures with
LN cells from BN-PBMC (days 60–80) rats are shown on the right (gray bar). (c) Responder LN cells (1 106) were cultured for 5 days with
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MLR in the presence of 0.5 106 CD4þT cells from naı¨ve LW LN were used as controls. Proliferation was measured by incorporation
of 3H-thymidine and expressed as c.p.m. or stimulation index. JPo0.05 vs naı¨ve, yPo0.05 vs medium, *Po0.05 vs transwell and
KPo0.05 vs coculture without anti-IL-10 by analysis of variance.
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rejected grafts from untreated animals. More importantly,
CD4þ T cells isolated from PBMC-tolerized grafts 5 days
post-transplant were hyporesponsive against donor antigens,
had regulatory activity on a naı¨ve MLR, and were capable
of partially prolonging kidney allograft when adoptively
transferred into naı¨ve rats.
The presence of Treg in tolerized grafts and the ability of
lymphocytes infiltrating the graft to transfer tolerance have
been reported in various models.19,25,31–36 Graca et al.34
showed that recipient T cells infiltrating a skin graft tolerized
by anti-CD4 and anti-CD8 mAb could expand when the skin
graft was retransplanted into T cell-deficient RAG1/ mice
and could prevent the rejection of a subsequent fresh skin
graft. T cells isolated from rat kidney allografts tolerated by
anti-CD4 mAb, as early as 14 days after transplantation, were
enriched with Treg, at variance with splenic T cells.37 In
another model of tolerance induced by non-depleting
anti-CD4 mAb in sensitized rats, a higher percentage of Treg
was found within tolerated heart grafts than in the spleen
and draining LNs.33 These authors suggested that Treg
first expand at the graft site before they migrate toward the
lymphoid organs. This interpretation fits with our observa-
tion of early post-transplant appearance of Treg in the graft
in the face of late appearance in the LN.
At variance with our and the above findings, Kitade et al.25
isolated Treg from lymphoid organs of donor-specific
transfusion-tolerized rat heart recipients as early as 5 days
post-transplant but failed to find Tregs in tolerized hearts at
that time point. This observation indicates that the origin
and trafficking of Treg is dependent on the experimental
setting used to induce tolerance as well as on the strain
combinations and the specific transplanted organ.
Several subsets of CD4þ Treg have been identified. Among
them, Tr type 1 cells are generated in vitro after antigen
stimulation in the presence of IL-10 and are able to suppress
autoimmune diseases in vivo.38 These cells express very low
levels of CD25 antigen39 and secrete high levels of IL-10, which
mediates their suppressive effect.38 Once activated, Tr-1 cells
suppress T-cell response in an antigen nonspecific manner.
Indeed, Tr type 1 clones that are specific for filamen-
tous hemagglutinin from Bordetella pertussis suppress proli-
feration by a Th1 clone against an unrelated antigen, influenza
virus hemagglutinin.40 Other studies in rodent models have
shown that tolerance to organ transplantation is associated
with the formation of a population of CD4þCD25þ Treg,
characterized by their ability to transfer tolerance when
infused into secondary naı¨ve recipients.41,42 CD4þCD25þ
Treg are anergic cells but promptly proliferate in response
to IL-243 and require direct cell-to-cell contact to exert their
immunomodulatory activity.43 CD4þCD25þ T cells release
IL-10, but this cytokine seems not to be involved in their
suppressive effect in vitro.28,44 On the other hand, IL-10 is
required for CD4þCD25þ Treg activity in vivo in models of
autoimmune disease45 and organ transplantation.41,42
In contrast with the above reports, Kitade et al.25 showed
that regulatory activity induced by donor-specific transfusion
was not restricted to the CD4þCD25þ subset, but was also
present in the CD4þCD25 subset. Consistent with these
data, here we found regulatory activity not only in
CD4þCD25þ but also in CD4þCD25 T cells isolated
from GIL of PBMC-treated rats. Treg isolated from GIL were
anergic cells that proliferated in response to IL-2 and cell-to-
cell contact potentiated their suppressive activity. The latter
features match with the CD4þCD25þ Treg phenotype. On
the other hand, GIL-Treg expressed moderate levels of IFNg,
high levels of IL-10, and their immunomodulatory activity
was not donor-specific and was IL-10-dependent, as addition
of an anti-IL-10 antibody to coculture MLR significantly
reverted their suppressive effect on naı¨ve T cells. The latter
properties of GIL-Treg are shared with Tr type 1 cells.40,46
Presumably the anti-third-party suppression by GIL is due to
the release of soluble IL-10, which may act on any T cell in
close proximity. High levels of IL-10 were also found in
CD4þ -GIL isolated from rejected kidneys of untreated rats;
however, the latter cells differed from GIL-Treg for having
high expression of the Th1 cytokines IFNg and IL-2, which
unmasks their activation state.
One possible explanation of all the above findings could be
that in tolerized kidney allografts are accumulating different
subset-suppressor cells that are programed to inhibit allo-
reactivity either by a cell-contact-dependent mechanism or by
the secretion of IL-10. Alternatively, the two phenotypes may
underscore different maturation steps of a single Treg subset.
Of note, the phenotype of GIL-Treg differed from that
of Treg found in LN of long-term surviving rats13 because
the latter were donor specific, had a lower expression of IFNg
and IL-10 than GIL-Treg, and their suppressive activity
was IL-10-independent and cell-contact-dependent. Despite
donor-specificity of Treg, LN cells from long-term surviving
animals were partially hyporesponsive toward third-party
antigens as well, suggesting that additional mechanisms such
as partial peripheral deletion may also concur to maintain
tolerance in our model.13
We hypothesize that in our model of tolerance induction
to allogenic kidney transplant by donor PBMC infusion, a
cohort of anergic T cells emerging from the thymus early
after donor cell infusion might prevent graft rejection,
allowing the graft to heal and function. Early induction of
anergy will have the permissive role to prevent early graft
disruption, thus allowing Treg to be formed in the absence of
irreversible graft damage, which instead occurs in the kidneys
of untreated rats. In this phase, regulation is not donor
specific. Finally, the late phase of tolerance is maintained by
the appearance of donor-specific Treg in LN, which could
either derive from delayed migration of Treg from the graft to
lymphoid organs or be newly generated in LN by prolonged
exposure to donor antigens shed from the graft.
MATERIALS AND METHODS
Animals
Inbred male rats weighing 175–200 g (10-week-old) were used
(Charles River Italia, Calco, Italia). LWs (RT1l) served as recipients,
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BNs (RT1n) or WFs (RT1u) served as donors. Animal care and
treatment were conducted in conformity with institutional guide-
lines in compliance with national and international laws and polices.
Animals were maintained in conventional animal facilities and had
free access to standard rat chow and tap water.
Kidney transplantation
PBMC (70 106) were injected intravenously into LW rats. Starting on
the day of cell infusion, LW rats also received a short course of
cyclosporine A (10 mg/kg/day intramuscularly) for 15 days for donor
cell engraftment. After 5 day cyclosporine A washout (day 0), animals
underwent orthotopic kidney transplantation from BN rats.5 Tolerance
was defined as kidney-graft survival of more than 60 days. To study
mechanisms underlying tolerance induction, rats were killed 20 days
after donor PBMC infusion (day 0, n¼ 11) and at day 5 (n¼ 11),
15 (n¼ 3), 30 (n¼ 3), and 60–80 (n¼ 15) after transplant-
ation to obtain LN cells, thymocytes and graft infiltrating lymphocytes.
Isolation of GIL and T-cell subsets
Kidneys were perfused before harvesting, minced and then incubated
with 1 mg/ml type IV Collagenase (Sigma, St Louis, MO, USA). The
lymphocytes were then separated on density gradient centrifugation
using lympholyte-rat (Cedarlane, Ontario, Canada).47
CD4þ T cells were isolated from LN and GIL by positive selection
with mouse anti-rat CD4 mAb or by negative selection (CD4þ -
enriched cells) by depletion of CD8þ and MHCIIþ cells.13
CD4þCD25þ T cells isolated from GIL-CD4þ -enriched population
by positive selection with mouse anti-rat CD25 (OX-39) mAb (Serotec,
Oxford, UK). CD4þCD25 T cells were isolated from GIL by
depletion of CD25þ cells and subsequent positive selection of CD4þ
cells. Single-positive CD4 thymocytes were purified by depletion of
CD8þ cells (single-positive and double-positive CD8 thymocytes) and
MHCIIþ cells, followed by positive selection with mouse anti-rat CD4
(W3/25) mAb (Serotec). All cell isolations were performed using goat
anti-mouse Immunoglobulin G-coupled microbeads and magnetic
separation on medium size (MS) or large size (LS) columns as
appropriate (Miltenyi Biotech, Bergish Gladbach, Germany). Isolated
cells were analyzed by fluorescence-activated cell sorting.
MLR, coculture MLR, and transwell assay
MLR was performed in triplicate as described.13 The proliferative
response was expressed as stimulation index, SI¼ c.p.m. from
allogeneic MLR/c.p.m. from control combination or as c.p.m. (for
experiments with IL-2, where the c.p.m. measured in syngeneic
combinations were subtracted as blanks). For coculture MLR, naı¨ve
LW LN cells (1 106) were cultured with irradiated splenocytes
(1.5 106) from BN, WF, or LW rats in the presence of 0.5 106
cells isolated from thymus, LN, or GIL of BN-PBMC-infused or
naı¨ve animals. In some experiments, 2 mg/ml of polyclonal rabbit
anti-rat IL-10 antibody (Insight Biotechnology, Wembley, UK) was
added to the culture. Transwell assays were performed in transwell
plates of 0.4 mm pore size. Naı¨ve LW LN cells (1 106) were
stimulated with 1 106 irradiated BN splenocytes in the lower
compartment, 0.5 106 GIL cells from BN-PBMC-infused rats
cultured with 0.5 106 irradiated BN splenocytes or medium alone
were placed in the upper compartment. The proliferative response
was evaluated on day 5 by 3H-thymidine incorporation.
Flow cytometric analysis
Cells were stained with mouse anti-rat CD4, mouse anti-rat CD8
(OX-8), mouse anti-rat CD25, and mouse anti-rat MHCII (OX-6)
mAbs (Serotec) followed by fluorescein isothiocyanate–goat anti-
mouse immunoglobulin (Pharmingen, San Diego, CA, USA) as
secondary antibody. The percentage of positive cells was determined
by flow cytometric analysis (FACSorts Becton Dickinson & Co.,
Mountain View, CA, USA).
Immunofluorescence staining
Frozen kidney sections (3mm) were cut with a cryostat, air-dried,
and fixed in acetone.
The sections were incubated with phycoerythrin-conjugated
mouse anti-rat CD4 mAb (Serotec) and rabbit anti-rat Foxp3 mAb
(Santa Cruz, CA, USA). Cy5-conjugated goat anti-rabbit (Jackson
Immunoresearch Laboratories, West Grove, PA, USA) was used as
secondary antibody. The double immunofluorescence staining was
analyzed by an inverted confocal laser scanning microscope (LS 510
Meta; Zeiss, Jena, Germany). The numbers of total CD4þ T cells
and CD4þ Foxp3þ were counted in at least 10 randomly selected
high-power microscope fields (original magnification  400) for
each animal. Results were expressed as percentage of Foxp3þ cells
within total CD4þ population.
Real-time quantitative polymerase chain reaction analysis
Quantitative analysis of IFNg, IL-10, IL-2 gene expression in CD4þ
T cells from LN and GIL was performed by real time reverse
transcriptase-polymerase chain reaction on a TaqMan ABI PRISM
5700 sequence-detection system (PE Applied Biosystems, Foster
City, CA) with SYBR green polymerase chain reaction core
reagents (Applied Biosystems), in combination with optimal primer
concentrations. The amplification profile consisted of 501C for
2 min, 951C for 10 min, and 40 cycles of 951C for 15 s and 601C for
1 min. To assess the overall cDNA content, glyceraldehyde-3-
phosphate dehydrogenase served as housekeeping gene. We used
the DD threshold cycle technique to calculate cDNA content in each
sample using the cDNA expression in CD4þ T cells from naı¨ve rats
as reference (calibrator).
Statistical analysis
Data are mean7s.e. Statistical analysis was performed by one-way
analysis of variance. Statistical level of significance was defined as
Po0.05.
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